The Company is seeking an experienced international business development professional to supplement the Company/s business development and licensing efforts.
The Senior Director of Business Development will be the primary resource to lead and direct the Company’s business development and licensing efforts for its current product portfolio and will also be involved with in-licensing activities as well as out-licensing.
Among the Responsibilities for this role include:
Identification and evaluation of potential out-licensing candidates for the existing product portfolio of the Company.
Primary negotiation interface with targets and licensees.
Recommendation of deal terms and structure.
Coordination of external advisers for regulatory and legal matters with respect to licensing agreements.
Attendance at various international life science conferences.
Coordination of due diligence and participation with due diligence team for in-licensing and other BD opportunities.
Primary interface with foreign nationals at licensing candidates.
Travels to foreign countries, meets with licensee management, evaluates local country licensing candidates, conducts due diligence of licensee and assists licensee in performing due diligence with Company internal resources.
Establishes recommended priorities and maintains status of targets and potential licensees by country.
Provides ongoing communication with the senior management team and other stakeholders.
10-20 Years of Pharma experience with 10 years of BD experience.
Business development experience and successful track record of deal completion.
College graduate with advanced degree preferred.
Well organized and has a broad breadth of understanding of industry and deal process.
Ability to work remotely, self starter, mature and strong communication and negotiation skills.
Additional Salary Information: This role can be either as a consultant (full time) or as an employee of the Company. Relocation is not required but periodic travel to HQ is expected as well as extensive international travel around the globe including Europe, LATAM, India, Asia and ROW.
About Rockwell Medical
Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis.
Rockwell's recent FDA approved drug Triferic is indicated for iron replacement and maintenance of hemoglobin ...in hemodialysis patients. Triferic delivers iron to patients during their regular dialysis treatment, using dialysate as the delivery mechanism. Triferic has demonstrated that it safely and effectively delivers sufficient iron to the bone marrow and maintains hemoglobin, without increasing iron stores (ferritin). Rockwell intends to market Triferic to hemodialysis patients in the U.S. dialysis market and globally.
Rockwell's FDA approved generic drug Calcitriol is for treating secondary hyperparathyroidism in dialysis patients. Calcitriol (active vitamin D) injection is indicated in the management of hypocalcemia in patients undergoing chronic renal dialysis. It has been shown to significantly reduce elevated parathyroid hormone levels. Reduction of PTH has been shown to result in an improvement in renal osteodystrophy. Rockwell intends to market Calcitriol to hemodialysis patients in the U.S. dialysis market.
Rockwell is also an established manufacturer and leader in delivering high-quality hemodialysis concentrates/dialysates to dialysis providers and distributors in the U.S. and abroad. As one of the two major suppliers in the U.S., Rockwell's products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell has three U.S. manufacturing/distribution facilities.
Rockwell's exclusive renal drug therapies support disease management initiatives to improve the quality of life and care of dialysis patients and are intended to deliver safe and effective therapy, while decreasing drug administration costs and improving patient convenience. Rockwell Medical is developing a pipeline of drug therapies, including extensions of Triferic for indications outside of hemodialysis. Please visit www.rockwellmed.com for more information.